IBM Partners with Bayer 04 Leverkusen to Enhance Football Data Analysis Efficiency
Written by Emily J. Thompson, Senior Investment Analyst
Source: PRnewswire
Updated: 54 minutes ago
0mins
Source: PRnewswire
- Digital Advancement: The collaboration between IBM and Bayer 04 Leverkusen has resulted in an AI solution operated entirely on the IBM Cloud, which significantly reduces time-consuming manual analyses, thereby enhancing the efficiency of analysts and decision-makers.
- Technology Integration: The new platform combines IBM watsonx.ai Studio and Runtime to analyze game and training data faster and more accurately, providing targeted professional support for teams and promoting a data-driven future.
- Industry Pioneer: Bayer 04 Leverkusen positions itself as a pioneer in the application of digital solutions, and this partnership marks a milestone in the digitalization of critical processes, further enhancing its competitiveness in professional football.
- Cloud Computing Advantages: The integration of IBM Cloud Object Storage and Serverless Computing not only offers highly available storage for video content but also provides flexible scalability for the platform, supporting future technological innovations and business growth.
IBM.N$0.0000%Past 6 months

No Data
Analyst Views on IBM
Wall Street analysts forecast IBM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for IBM is 295.18 USD with a low forecast of 210.00 USD and a high forecast of 350.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast IBM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for IBM is 295.18 USD with a low forecast of 210.00 USD and a high forecast of 350.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 302.620

Current: 302.620

Outperform
initiated
$360
Reason
Oppenheimer initiated coverage of IBM with an Outperform rating and $360 price target. The firm says its bullish stance is predicated on its belief IBM's software portfolio should see sustained "double-digit" revenue growth driven by strength in Automation and improving growth in RedHat, consulting should grow at a sustained "low single digits" with recovery in application development/management, and additional revenue optionality with creation and management of AI applications. Oppenheimer believes these drivers will result in strong expansion activity with existing customers, and drive continued gross and pre-tax margin expansion. The stock should also re-rate higher when IBM's pivot to software is more widely appreciated, it adds.
Melius Research
Benjamin Reitzes
maintain
Reason
Melius Research
Benjamin Reitzes
After having spent a day at IBM's quantum lab and meeting with Jay Gambetta, Director of IBM Research, Melius Research analyst Benjamin Reitzes reiterates a Buy rating on the shares, telling investors that IBM has the most quantum computers in use today, "by far," and arguing that its potential in quantum "looks like it could amount to billions of high-margin annualized revenue" starting in 2029. The "Starling" line of quantum computers has the potential to unlock capabilities to run revolutionary applications on a 200 qubit platform with an error correction rate that "finally allows this technology cross the chasm," according to the analyst, who adds that IBM seems to have "the ingredients to win in Quantum since it arguably has the best hardware roadmap and the mindshare of developers with its Qiskit platform."
maintain
$200 -> $210
Reason
UBS raised the firm's price target on IBM to $210 from $200 and keeps a Sell rating on the shares. The firm, which raised its price target as it rolls its valuation basis to calendar year 2027, argues that "key metrics flash caution" into 2026 and that it is "not too early to focus on the puts and takes heading into" the outlook for next year as Red Hat and TP constant currency growth "disappoint" in Q3.
Equal Weight
maintain
$256 -> $252
Reason
Morgan Stanley lowered the firm's price target on IBM to $252 from $256 and keeps an Equal Weight rating on the shares. Software results surprised to the downside, with Red Hat and TP decelerations "standing out," the analyst tells investors. While Infrastructure and Consulting beats were "positive surprises," IBM now has more work cutout to reaccelerate software growth to hit 5%-plus revenue growth in 2026, the analyst added.
About IBM
International Business Machines Corporation is a provider of global hybrid cloud and artificial intelligence (AI) and consulting expertise. The Company’s segments include Software, Consulting, Infrastructure and Financing. The Software segment includes hybrid cloud and AI platforms, which allow clients to realize their digital and AI transformations across the applications, data, and environments in which they operate. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment is focused on the hybrid cloud infrastructure market, providing on-premises and cloud-based server and storage solutions. In addition, it offers a portfolio of life-cycle services for hybrid cloud infrastructure deployment. The Financing segment provides client and commercial financing, facilitating its clients’ acquisition of hardware, software and services. It helps clients in more than 175 countries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.